Topiramate in the long-term treatment of binge-eating disorder associated with obesity

Journal of Clinical Psychiatry

Volumn 65, Issue 11, 2004, Pages 1463-1469

  McElroy, Susan L ^a   Shapira, Nathan A ^b   Arnold, Lesley M ^a   Keck Jr , Paul E ^a   Rosenthal, Norman R ^c   Wu, Shu Chen ^c   Capece, Julie A ^c   Fazzio, Lydia ^c   Hudson, James I ^d,e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

^d MCLEAN HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; PLACEBO; TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BULIMIA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PATIENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; BODY MASS INDEX; BODY WEIGHT; BULIMIA; COMORBIDITY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FRUCTOSE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OBESITY; OBSESSIVE-COMPULSIVE DISORDER; PATIENT COMPLIANCE; PATIENT DROPOUTS; PLACEBOS; TREATMENT OUTCOME;

EID: 16544363331     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n1104     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Williamson DA, Martin CK. Binge eating disorder: a review of the literature after publication of DSM-IV. Eat Weight Disord 1999;4:103-114
3. Dingemans AE, Bruna MJ, van Furth EF. Binge eating disorder: a review. Int J Obes Relat Metab Disord 2002;26:299-307 (Pubitemid 34226154)
4. Fairburn CG, Brownell KD, eds. Eating Disorders and Obesity, Second Edition. New York, NY: Guilford Press; 2002
5. Spitzer RL, Devlin M, Walsh BT, et al. Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203
6. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-153 (Pubitemid 23089545)
7. Smith DE, Marcus MD, Lewis CE, et al. Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998;20:227-232 (Pubitemid 29072339)
8. Adami GF, Gandolfo P, Bauer B, et al. Binge eating in massively obese patients undergoing bariatric surgery. Int J Eat Disord 1995;17:45-50
9. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81:1001-1024 (Pubitemid 32895997)
10. Carter WP, Hudson JI, Lalonde JK, et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003;34:S74-S88 (Pubitemid 36935715)
11. Appolinario JC, McElroy SL. Pharmacological approaches in the treatment of binge eating disorder. Curr Drug Targets 2004;5:301-307 (Pubitemid 38372314)
12. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998;155:1756-1762 (Pubitemid 28547503)
13. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000;157:1004-1006 (Pubitemid 30412354)
14. Arnold LM, McElroy SL, Hudson JI, et al. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 2002:63;1028-1033 (Pubitemid 35388063)
15. McElroy SL, Hudson JI, Malhotra S, et al. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry 2003;64:807-813 (Pubitemid 36897217)
16. Appolinario JC, Bacaltchuk J, Sichieri R, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge eating disorder. Arch Gen Psychiatry 2003;60:1109-1112 (Pubitemid 37429650)
17. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:255-261 (Pubitemid 41110450)
18. Langtry HD, Gillis JC, Davis R. Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752-773 (Pubitemid 27480245)
19. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 1997;19:1294-1308 (Pubitemid 28133269)
20. Shank RP, Gardocki JF, Streeter AJ, et al. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000;41(suppl 1):S3-S9 (Pubitemid 30202333)
21. Reife R, Pledger G, Wu S-C. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(suppl 1):S66-S71 (Pubitemid 30202345)
22. White HS. Topiramate: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, et al, eds. Antiepileptic Drugs, Fifth Edition. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:719-726
23. Ben-Menachem E, Axelsen M, Johansen EH, et al. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003;11:556-562 (Pubitemid 41202417)
24. Bray GA, Hollander P, Klein S, et al. A 6 month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722-733 (Pubitemid 41151598)
25. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 2000;61:368-372 (Pubitemid 30345939)
26. Appolinario JC, Fontenelle LF, Papelbaum M, et al. Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 2002;47:271-273 (Pubitemid 34614686)
27. Schmidt do Prado-Lima PA, Bacaltchuck J. Topiramate in treatment-resistant depression and binge-eating disorder. Bipolar Disord 2002;4:271-273
28. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry 2000;157:854-866 (Pubitemid 30412334)
29. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (Research Version 2/96 Final). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996
30. National Institute of Mental Health. CGI: Clinical Global Impressions. In: Guy W, Bonato RR, eds. Manual for the ECDEU Assessment Battery, Second Edition. Chevy Chase, Md: National Institute of Mental Health; 1970:12.1-12.6
31. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
32. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry 1989;46:1012-1016
33. Stanley BG, Ha LH, Spears LC, et al. Lateral hypothalamic injections of glutamate, kainic acid, D,L-a-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-d-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 1993;613:88-95 (Pubitemid 23170358)
34. Zeni LA, Seidler HB, De Carvalho NA, et al. Glutamatergic control of food intake in pigeons: effects of central injections of glutamate, NMDA, and AMPA receptor agonists and antagonists. Pharmacol Biochem Behav 2000;65:67-74
35. Duva MA, Tomkins EM, Moranda LM, et al. Reverse microdialysis of N-methyl-d-aspartic acid into the lateral hypothalamus of rats: effects on feeding and other behaviors. Brain Res 2001;921:122-132 (Pubitemid 33096291)
36. Duva MA, Tomkins EM, Moranda LM, et al. Regional differences in feeding and other behaviors elicited by N-methyl-d-aspartic acid in the rodent hypothalamus: a reverse microdialysis mapping study. Brain Res 2002;925:141-147 (Pubitemid 34131630)
37. Zheng H, Patterson C, Berthoud H-R. Behavioral analysis of anorexia produced by hindbrain injections of AMPA receptor antagonist NBQX in rats. Am J Physiol Regul Integr Comp Physiol 2002;282:R147-R155 (Pubitemid 34663921)
38. Stunkard A, Berkowitz R, Tanrikut C, et al. d-Fenfluramine treatment of binge eating disorder. Am J Psychiatry 1996;153:1455-1459 (Pubitemid 26365461)
39. Schiffer WK, Gerasimov MR, Marsteller DA, et al. Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 2001;42:196-198 (Pubitemid 32999627)
40. Fairburn CG, Cooper Z, Doll HA, et al. The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000;57:659-665 (Pubitemid 30445857)
41. Romano SJ, Halmi KA, Sarkar NP, et al. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002;159:96-102 (Pubitemid 41070733)
42. McElroy SL, Kotwal R. Binge eating. In: Hollander E, Stein D, eds. Handbook of Impulse Control Disorders. Washington, DC: American Psychiatric Publishing. In press